Human Genome CEO Sees Benlysta Driving Growth

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

June 27 (Bloomberg) -- Thomas Watkins, chief executive officer of Human Genome Sciences Inc., talks about Human Genome's Benlysta therapy for Lupus. Watkins also discusses drug pricing. He speaks with Shannon Pettypiece at the 2011 BIO International Convention in Washington on Bloomberg Television's "Fast Forward." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change